Literature DB >> 19267259

In vivo study of porous strontium-doped calcium polyphosphate scaffolds for bone substitute applications.

Meng Tian1, Feng Chen, Wei Song, Yancheng Song, Yuanwei Chen, Changxiu Wan, Xixun Yu, Xiaohua Zhang.   

Abstract

The purpose of this study was to investigate in vivo biocompatibility and osteogenesis as well as degradability of the porous strontium-doped calcium polyphosphate (SCPP) scaffolds as a biomaterial for bone substitute applications. The evaluation was performed on a rabbit model over a period of 16 weeks by histology combined with image analysis, X-ray microradiography and immunohistochemistry methods. The histological and X-ray microradiographic results showed that the SCPP scaffold exhibited good biocompatibility and extensive osteoconductivity with host bone. Moreover, a significant more bone formation was observed in the SCPP group compared with that in the CPP group, especially at the initial stage after implantation. New bone volumes (NBVs) of the SCPP group determined at week 4, 8 and 16 were 14, 27 and 45%, respectively. Accordingly, NBVs of the CPP group were 10, 19 and 40%. Immunohistochemical results revealed that both the expression of collagen type I and bone morphogenetic proteins in the SCPP group were higher than that in the CPP group, which might be associated with the release of strontium ions during the implantation. In addition, during 16 weeks implantation the SCPP scaffold exhibited similar degradability with the CPP scaffold in vivo. Both scaffolds showed the greatest degradation rate for the first 4 weeks, and then the degradation rate gradually decreased. The results presented in this study demonstrated that SCPP scaffold can be considered as a biocompatible material, making it attractive for bone substitute application purposes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19267259     DOI: 10.1007/s10856-009-3713-5

Source DB:  PubMed          Journal:  J Mater Sci Mater Med        ISSN: 0957-4530            Impact factor:   3.896


  26 in total

1.  Incorporation of three types of bone block implants in the facial skeleton.

Authors:  M A Merkx; J C Maltha; H P Freihofer; A M Kuijpers-Jagtman
Journal:  Biomaterials       Date:  1999-04       Impact factor: 12.479

2.  Tissue-engineered growth of bone by marrow cell transplantation using porous calcium metaphosphate matrices.

Authors:  Y M Lee; Y J Seol; Y T Lim; S Kim; S B Han; I C Rhyu; S H Baek; S J Heo; J Y Choi; P R Klokkevold; C P Chung
Journal:  J Biomed Mater Res       Date:  2001-02

3.  Interfacial behaviour of strontium-containing hydroxyapatite cement with cancellous and cortical bone.

Authors:  G X Ni; W W Lu; B Xu; K Y Chiu; C Yang; Z Y Li; W M Lam; K D K Luk
Journal:  Biomaterials       Date:  2006-06-15       Impact factor: 12.479

4.  Osteoclastic resorption of calcium phosphate ceramics with different hydroxyapatite/beta-tricalcium phosphate ratios.

Authors:  S Yamada; D Heymann; J M Bouler; G Daculsi
Journal:  Biomaterials       Date:  1997-08       Impact factor: 12.479

5.  Development of a strontium-containing hydroxyapatite bone cement.

Authors:  Dagang Guo; Kewei Xu; Xiaoyun Zhao; Yong Han
Journal:  Biomaterials       Date:  2005-07       Impact factor: 12.479

6.  Strontium ranelate inhibits bone resorption while maintaining bone formation in alveolar bone in monkeys (Macaca fascicularis).

Authors:  J Buehler; P Chappuis; J L Saffar; Y Tsouderos; A Vignery
Journal:  Bone       Date:  2001-08       Impact factor: 4.398

7.  Incorporation and distribution of strontium in bone.

Authors:  S G Dahl; P Allain; P J Marie; Y Mauras; G Boivin; P Ammann; Y Tsouderos; P D Delmas; C Christiansen
Journal:  Bone       Date:  2001-04       Impact factor: 4.398

8.  S12911-2 reduces bone loss induced by short-term immobilization in rats.

Authors:  M Hott; P Deloffre; Y Tsouderos; P J Marie
Journal:  Bone       Date:  2003-07       Impact factor: 4.398

9.  Effects of strontium on calcium metabolism in rats. I. A distinction between the pharmacological and toxic doses.

Authors:  T Morohashi; T Sano; S Yamada
Journal:  Jpn J Pharmacol       Date:  1994-03

10.  Normal matrix mineralization induced by strontium ranelate in MC3T3-E1 osteogenic cells.

Authors:  A Barbara; P Delannoy; B G Denis; P J Marie
Journal:  Metabolism       Date:  2004-04       Impact factor: 8.694

View more
  17 in total

1.  In vitro study in stimulating the secretion of angiogenic growth factors of strontium-doped calcium polyphosphate for bone tissue engineering.

Authors:  Fei Liu; Xu Zhang; Xixun Yu; Yuanting Xu; Ting Feng; Dawei Ren
Journal:  J Mater Sci Mater Med       Date:  2011-02-02       Impact factor: 3.896

2.  Application of K/Sr co-doped calcium polyphosphate bioceramic as scaffolds for bone substitutes.

Authors:  Huixu Xie; Qianbin Wang; Qingsong Ye; Changxiu Wan; Longjiang Li
Journal:  J Mater Sci Mater Med       Date:  2012-02-05       Impact factor: 3.896

3.  Direct cytotoxicity evaluation of 63S bioactive glass and bone-derived hydroxyapatite particles using yeast model and human chondrocyte cells by microcalorimetry.

Authors:  A Doostmohammadi; A Monshi; M H Fathi; S Karbasi; O Braissant; A U Daniels
Journal:  J Mater Sci Mater Med       Date:  2011-07-24       Impact factor: 3.896

Review 4.  Understanding of dopant-induced osteogenesis and angiogenesis in calcium phosphate ceramics.

Authors:  Susmita Bose; Gary Fielding; Solaiman Tarafder; Amit Bandyopadhyay
Journal:  Trends Biotechnol       Date:  2013-09-06       Impact factor: 19.536

5.  Strontium doping of bone graft extender.

Authors:  Marianne T Vestermark; Ellen-Margrethe Hauge; Kjeld Soballe; Joan E Bechtold; Thomas Jakobsen; Jorgen Baas
Journal:  Acta Orthop       Date:  2011-09-06       Impact factor: 3.717

6.  In vivo and clinical application of strontium-enriched biomaterials for bone regeneration: A systematic review.

Authors:  N Neves; D Linhares; G Costa; C C Ribeiro; M A Barbosa
Journal:  Bone Joint Res       Date:  2017-06       Impact factor: 5.853

7.  Biomimetic mineralized strontium-doped hydroxyapatite on porous poly(l-lactic acid) scaffolds for bone defect repair.

Authors:  Min Ge; Kun Ge; Fei Gao; Weixiao Yan; Huifang Liu; Li Xue; Yi Jin; Haiyun Ma; Jinchao Zhang
Journal:  Int J Nanomedicine       Date:  2018-03-20

8.  The Feasibility and Functional Performance of Ternary Borate-Filled Hydrophilic Bone Cements: Targeting Therapeutic Release Thresholds for Strontium.

Authors:  Kathleen MacDonald; Richard B Price; Daniel Boyd
Journal:  J Funct Biomater       Date:  2017-07-14

Review 9.  Effect of microporosity on scaffolds for bone tissue engineering.

Authors:  Ke Zhang; Yubo Fan; Nicholas Dunne; Xiaoming Li
Journal:  Regen Biomater       Date:  2018-02-05

10.  Effects of Strontium-Doped β-Tricalcium Scaffold on Longitudinal Nuclear Factor-Kappa Beta and Vascular Endothelial Growth Factor Receptor-2 Promoter Activities during Healing in a Murine Critical-Size Bone Defect Model.

Authors:  Mersedeh Tohidnezhad; Yusuke Kubo; Philipp Lichte; Tobias Heigl; Diana Roch; Nazanin Barahmand Pour; Christian Bergmann; Tolga Taha Sönmez; Jennifer Vanessa Phi Hock; Athanassios Fragoulis; Felix Gremse; Stefanie Rosenhain; Alexander Slowik; Michaela Bienert; Nisreen Kweider; Christoph Jan Wruck; Holger Jahr; Frank Hildebrand; Hans Christoph Pape; Sabine Neuß; Horst Fischer; Thomas Pufe
Journal:  Int J Mol Sci       Date:  2020-05-01       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.